Paul Grayson was previously chief executive of Fate Therapeutics, managing director of venture capital firm Sanderling Ventures and founding executive chairman of Senomyx.

Joseph Doyle, Brainlab's chief financial officer, said: "Jan Medical is introducing an entirely new field of diagnostics that can impact everything from patient triage to surgical treatment."

Fidelity Biosciences and private equity firm TPG Biotech co-lead $45m A round for Ultragenyx Pharmaceutical.

Founded by industrialist Ajay Piramal and former State Bank of India chairman, AK Purwar, the investors in the $111m healthcare fund will be Indian companies and high net worth individuals, according to news provider Financial Express.

The corporate venturing arm of GlaxoSmithKline has joined peer Merck in backing a genetic diagnostics company. One of Glaxo's executives has joined HTG's board.

Before Inventages, D'Abbadie worked at Technikos, a UK-based medical device venture capital firm, and has joined Spark Impact.

Alan Lewis, executive president of Ambit, said: "Our existing investors have reaffirmed their confidence in the company, providing us with sufficient funding [$30m] to pursue our strategy and enabling us to withdraw our plans for an initial public offering."

Venture capital firm Essex Woodlands Health Ventures led the $45m round for Revance Therapeutics, which also included CNF Investments and others.

Venture philanthropy comes of age in medical hour of need

Eli Lilly's first portfolio company acquisition